Alyeska Investment Group’s Cidara Therapeutics CDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-4,628
| Closed | -$481K | – | 378 |
|
|
2018
Q2 | $481K | Sell |
4,628
-212
| -4% | -$22K | ﹤0.01% | 388 |
|
|
2018
Q1 | $387K | Sell |
4,840
-44
| -0.9% | -$3.52K | ﹤0.01% | 384 |
|
|
2017
Q4 | $664K | Hold |
4,884
| – | – | 0.01% | 368 |
|
|
2017
Q3 | $791K | Buy |
4,884
+88
| +2% | +$14.3K | 0.01% | 402 |
|
|
2017
Q2 | $719K | Sell |
4,796
-146
| -3% | -$21.9K | 0.01% | 401 |
|
|
2017
Q1 | $771K | Sell |
4,942
-58
| -1% | -$9.05K | 0.01% | 429 |
|
|
2016
Q4 | $1.04M | Buy |
+5,000
| New | +$1.04M | 0.01% | 409 |
|
|
2015
Q4 | – | Sell |
-6,072
| Closed | -$1.55M | – | 377 |
|
|
2015
Q3 | $1.55M | Buy |
6,072
+481
| +9% | +$122K | 0.02% | 346 |
|
|
2015
Q2 | $1.57M | Buy |
+5,591
| New | +$1.57M | 0.02% | 349 |
|